3B BLACKBIO DX Financial Statement Analysis
|
||
The Revenues of 3B BLACKBIO DX have increased by 19.87% YoY .
The Earnings Per Share (EPS) of 3B BLACKBIO DX has increased by 23.71 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
3B BLACKBIO DX Last 5 Annual Financial Results
[BOM: 532067]
Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹74 Cr | ₹62 Cr | ₹81 Cr | ₹227 Cr | ₹29 Cr |
Expenses | ₹41 Cr | ₹33 Cr | ₹44 Cr | ₹77 Cr | ₹20 Cr |
Operating Profit (Excl OI) | ₹33 Cr | ₹29 Cr | ₹37 Cr | ₹150 Cr | ₹9.32 Cr |
Other Income | ₹13 Cr | ₹7.26 Cr | ₹6.90 Cr | ₹2.89 Cr | ₹1.60 Cr |
Interest | ₹0.12 Cr | ₹0.20 Cr | ₹0.11 Cr | ₹0.23 Cr | ₹0.33 Cr |
Depreciation | ₹1.06 Cr | ₹0.86 Cr | ₹0.67 Cr | ₹0.62 Cr | ₹0.54 Cr |
Profit Before Tax | ₹44 Cr | ₹35 Cr | ₹43 Cr | ₹152 Cr | ₹10 Cr |
Profit After Tax | ₹32 Cr | ₹26 Cr | ₹32 Cr | ₹114 Cr | ₹7.69 Cr |
Consolidated Net Profit | ₹32 Cr | ₹26 Cr | ₹32 Cr | ₹114 Cr | ₹7.68 Cr |
Earnings Per Share (Rs) | ₹37.46 | ₹30.28 | ₹42.98 | ₹152.00 | ₹10.25 |
PAT Margin (%) | 43.31 | 41.94 | 39.93 | 50.22 | 26.62 |
ROE(%) | 15.42 | 14.98 | 22.59 | 138.73 | 28.15 |
ROCE(%) | 21.21 | 20.24 | 29.92 | 179.46 | 32.29 |
Total Debt/Equity(x) | 0.00 | 0.01 | 0.02 | 0.02 | 0.11 |
Key Financials |
||
Market Cap | : | ₹ 1,643.0 Cr |
Revenue (TTM) | : | ₹ 89.2 Cr |
Net Profit(TTM) | : | ₹ 43.5 Cr |
EPS (TTM) | : | ₹ 50.5 |
P/E (TTM) | : | 37.8 |
Industry Peers & Returns | 1W | 1M | 1Y |
3B BLACKBIO DX | 2.4% | 23.4% | 140.6% |
PI INDUSTRIES | -1.9% | -8.7% | 9.2% |
UPL | -0.5% | -8.4% | -10.7% |
BAYER CROPSCIENCE | -1.2% | -0.1% | 3.5% |
SUMITOMO CHEMICAL INDIA | -0.9% | -4.3% | 29.7% |
BASF INDIA | -1.1% | -3.5% | 85.3% |
RALLIS INDIA | 0.1% | -9.7% | 18.1% |
DHANUKA AGRITECH | -0.8% | -2.5% | 42.8% |
BHARAT RASAYAN | -2.4% | -15.5% | 11.1% |
3B BLACKBIO DX Revenues
[BOM: 532067]
Y-o-Y | 19.87 % |
5 Yr CAGR | 26.58 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹74 Cr | 19.87 | |
Mar2023 | ₹62 Cr | -23.32 | |
Mar2022 | ₹81 Cr | -64.43 | |
Mar2021 | ₹227 Cr | 685.25 | |
Mar2020 | ₹29 Cr | - |
3B BLACKBIO DX Operating Profit
[BOM: 532067]
Y-o-Y | 13.30 % |
5 Yr CAGR | 37.16 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹33 Cr | 13.30 | |
Mar2023 | ₹29 Cr | -21.53 | |
Mar2022 | ₹37 Cr | -75.27 | |
Mar2021 | ₹150 Cr | 1,509.67 | |
Mar2020 | ₹9.32 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -5.50 % |
5 Yr CAGR | 8.36 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 44.49% | -5.50 | |
Mar2023 | 47.08% | 2.35 | |
Mar2022 | 46% | -30.46 | |
Mar2021 | 66.15% | 104.99 | |
Mar2020 | 32.27% | - |
3B BLACKBIO DX Profit After Tax
[BOM: 532067]
Y-o-Y | 23.77 % |
5 Yr CAGR | 43.00 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹32 Cr | 23.77 | |
Mar2023 | ₹26 Cr | -19.45 | |
Mar2022 | ₹32 Cr | -71.72 | |
Mar2021 | ₹114 Cr | 1,383.25 | |
Mar2020 | ₹7.68 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 3.27 % |
5 Yr CAGR | 12.94 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 43.31 % | 3.27 | |
Mar2023 | 41.94 % | 5.03 | |
Mar2022 | 39.93 % | -20.49 | |
Mar2021 | 50.22 % | 88.66 | |
Mar2020 | 26.62 % | - |
3B BLACKBIO DX Earnings Per Share (EPS)
[BOM: 532067]
Y-o-Y | 23.71 % |
5 Yr CAGR | 38.26 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹37 | 23.71 | |
Mar2023 | ₹30 | -29.55 | |
Mar2022 | ₹43 | -71.72 | |
Mar2021 | ₹152 | 1,382.93 | |
Mar2020 | ₹10 | - |
3B BLACKBIO DX Return on Capital Employed (ROCE)
[BOM: 532067]
Y-o-Y | 4.79 % |
5 Yr CAGR | -9.97 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 21.21% | 4.79 | |
Mar2023 | 20.24% | -32.35 | |
Mar2022 | 29.92% | -83.33 | |
Mar2021 | 179.46% | 455.78 | |
Mar2020 | 32.29% | - |
3B BLACKBIO DX Share Price vs Sensex
Current Share Price | : | ₹1,910.5 |
Current MarketCap | : | ₹ 1,643.0 Cr |
Updated EOD on | : | Dec 30,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
3B BLACKBIO DX | 2.4% |
23.4% |
140.6% |
SENSEX | 0.3% |
-2.5% |
10% |
3B BLACKBIO DX related INDICES
You may also like the below Video Courses
FAQ about 3B BLACKBIO DX Financials
How the annual revenues of 3B BLACKBIO DX have changed ?
The Revenues of 3B BLACKBIO DX have increased by 19.87% YoY .
How the Earnings per Share (EPS) of 3B BLACKBIO DX have changed?
The Earnings Per Share (EPS) of 3B BLACKBIO DX has increased by 23.71 % YoY .
Intrinsic Value of PI INDUSTRIES LTD Intrinsic Value of UPL LTD Intrinsic Value of BAYER CROPSCIENCE LTD Intrinsic Value of SUMITOMO CHEMICAL INDIA LTD Intrinsic Value of BASF INDIA LTD |
PI INDUSTRIES LTD vs UPL LTD vs BAYER CROPSCIENCE LTD
SUMITOMO CHEMICAL INDIA LTD vs BASF INDIA LTD vs